Access the full text.
Sign up today, get DeepDyve free for 14 days.
Zhen Chen, Yingjie Shao, Min Fan, Qianfeng Zhuang, Kun Wang, W. Cao, Xianlin Xu, Xiaozhou He (2015)
Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.International journal of clinical and experimental pathology, 8 11
Tomokazu Kishiki, T. Masaki, H. Matsuoka, Takaaki Kobayashi, Yutaka Suzuki, N. Abe, Toshiyuki Mori, M. Sugiyama (2013)
Modified Glasgow prognostic score in patients with incurable stage IV colorectal cancer.American journal of surgery, 206 2
T. Nozoe, Mayuko Kohno, T. Iguchi, E. Mori, T. Maeda, A. Matsukuma, T. Ezaki (2012)
The prognostic nutritional index can be a prognostic indicator in colorectal carcinomaSurgery Today, 42
Chao-Wen Hsu, T. King, Hsin-Tai Wang, Jui‐Ho Wang (2011)
Factors that influence survival in unresectable metastatic or locally advanced colorectal cancerInternational Journal of Colorectal Disease, 26
A. Kinoshita, Hiroshi Onoda, N. Imai, Akira Iwaku, Mutumi Oishi, Ken Tanaka, Nao Fushiya, K. Koike, H. Nishino, M. Matsushima (2015)
The C-Reactive Protein/Albumin Ratio, a Novel Inflammation-Based Prognostic Score, Predicts Outcomes in Patients with Hepatocellular CarcinomaAnnals of Surgical Oncology, 22
I. Gockel, K. Dirksen, C. Messow, T. Junginger (2006)
Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus.World journal of gastroenterology, 12 23
A. Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortés-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Bail, C. Louvet, D. Hendler, F. Braud, C. Wilson, F. Morvan, A. Bonetti (2000)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 16
M. Torre, G. Nigri, M. Cavallini, P. Mercantini, V. Ziparo, G. Ramacciato (2012)
The Glasgow Prognostic Score as a Predictor of Survival in Patients with Potentially Resectable Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 19
K. Hirashima, Masayuki Watanabe, H. Shigaki, Y. Imamura, S. Ida, M. Iwatsuki, T. Ishimoto, S. Iwagami, Y. Baba, H. Baba (2013)
Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancerJournal of Gastroenterology, 49
J. Douillard, S. Siena, J. Cassidy, J. Tabernero, R. Burkes, M. Barugel, Y. Humblet, G. Bodoky, D. Cunningham, J. Jassem, F. Rivera, I. Kocáková, P. Ruff, M. Błasińska-Morawiec, M. Šmakal, J. Canon, M. Rother, K. Oliner, M. Wolf, J. Gansert (2010)
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 31
J. Hwang, Ha-Na Kim, Dae-Eun Kim, H. Choi, S. Jung, H. Shim, W. Bae, E. Hwang, Sang‐Hee Cho, I. Chung (2011)
Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancerBMC Cancer, 11
K. Maeda, Masatsune Shibutani, H. Otani, H. Nagahara, K. Sugano, Teturo Ikeya, N. Kubo, R. Amano, K. Kimura, K. Muguruma, Hiroaki Tanaka, K. Hirakawa (2014)
Low Nutritional Prognostic Index Correlates with Poor Survival in Patients with Stage IV Colorectal Cancer Following Palliative Resection of the Primary TumorWorld Journal of Surgery, 38
Abstract Despite the poor prognosis of unresectable colorectal cancer (CRC), some patients survive after intensive chemotherapy followed by complete resection of the primary and metastatic tumors. The pretreatment C-reactive protein/albumin ratio (CAR) is a significant prognostic indicator in various carcinomas. Therefore, in this retrospective study, we evaluated the prognostic significance of pretreatment CAR in patients with unresectable CRC. The 61 patients were diagnosed as having initially unresectable disease between January 2004 and December 2013. We analyzed the clinical courses of these patients. Blood samples were taken routinely at their first visit to our hospital. C-reactive protein (CRP), albumin (ALB), and carcinoembryonic antigen (CEA) were analyzed. The median survival time (MST) and 2-year overall survival (OS) of the patients was 9 months (range, 1–96 months) and 23%, respectively. The median CRP, ALB, CAR, and CEA levels of the patients were 2.2 mg/dL, 3.5 g/dL, 0.65, and 20.6 ng/mL, respectively. There was no correlation between CEA levels and the CAR. Patients were divided into two sub-groups using the median CAR level as the cut-off: high CAR (>0.65) and low CAR (≤0.65). Both MST and 2-year OS were significantly lower in the 30 high-CAR patients (4 months, 6.7%) than in the 31 low-CAR patients (13 months, 38.7%, p < 0.001). The primary tumors of three low-CAR patients could be removed after intensive chemotherapy. Thus, low-CAR patients with locally advanced CRC with or without distant metastasis may survive following intensive treatment, even if their tumors were previously deemed to be unresectable.
Indian Journal of Surgical Oncology – Springer Journals
Published: Sep 1, 2017
Keywords: surgical oncology; oncology; surgery
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.